EE226 Economic Evaluation of Trastuzumab in HER2-Positive Early Breast Cancer in Indonesia: A Cost-Effectiveness Analysis

Abstract

Authors

S. Khoirunnisa F.D.A. Suryanegara D. Setiawan M.J. Postma L. de Jong

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×